Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
The article announces several personnel changes within the nature biotechnology field including the appointment of Sol J. Barer to the board of directors of Aegerion Pharmaceuticals, appointment of Michelle Browner as chief executive officer (CEO) at Enlight Biosciences and resignation of Christoph Westphal from his post as president of the corporate healthcare venture capital fund SR One.